Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

117.65
Delayed Data
As of Sep 03
 -1.93 / -1.61%
Today’s Change
83.16
Today|||52-Week Range
140.72
+5.18%
Year-to-Date

Today’s Trading

Previous close119.58
Today’s open120.08
Day’s range117.09 - 121.14
Volume3,793,973
Average volume (3 months)4,882,749
Market cap$94.5B
Dividend yield--
Data as of 4:14pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.25%
Earnings growth (next 5 years)+24.13%
Revenue growth (last year)+17.89%
P/E ratio44.5
Price/Sales12.24
Price/Book14.67

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.21-0.26%
GSKGlaxoSmithKline-0.02-0.05%
BMYBristol-Myers Squibb-0.86-1.44%
ABBVAbbVie+0.60+0.98%
Data as of 4:01pm ET, 09/03/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)$1.21
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers